FOLD – amicus therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Amicus Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Amicus Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Amicus Therapeutics, Inc. (NASDAQ: FOLD) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Why Are Amicus, Immunocore, & Immuneering Stocks Trading Lower On Friday? [Yahoo! Finance]
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its "equal weight" rating re-affirmed by analysts at Morgan Stanley. They now have a $12.00 price target on the stock, down previously from $17.00.
Form 4 AMICUS THERAPEUTICS, For: Jan 02 Filed by: Rosenberg Ellen
Form 4 AMICUS THERAPEUTICS, For: Jan 02 Filed by: Prout Samantha
Form 4 AMICUS THERAPEUTICS, For: Jan 02 Filed by: Clark David Michael
Form 4 AMICUS THERAPEUTICS, For: Jan 02 Filed by: Campbell Bradley L
Form 4 AMICUS THERAPEUTICS, For: Jan 02 Filed by: Castelli Jeff
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.